Nasus Pharma (NSRX) Assets Average (2025)

Nasus Pharma (NSRX) reported Assets Average of $2.8 million for Q4 2025, up 316.15% quarter-over-quarter from $678000.0 in Q2 2025.

Nasus Pharma (NSRX) Assets Average (2025) Analysis & Trends

Nasus Pharma has reported Assets Average for 1 years, with the latest figure at $2.8 million in Q4 2025.

For the quarter ending Q4 2025, Assets Average changed N/A year-over-year to $2.8 million; the trailing twelve-month figure through Dec 2025 stood at $2.8 million (changed N/A YoY), and the FY2025 full-year result was $2.9 million, changed N/A from the prior year.
Assets Average for Q4 2025 stood at $2.8 million, up from $678000.0 in the prior quarter.
The five-year high for Assets Average was $2.8 million in Q4 2025, with the low at $678000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets Avg. (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn	83.03 Bn
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn	114.53 Bn
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn	200.05 Bn
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn	135.21 Bn
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn	132.78 Bn
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn	91.55 Bn
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn	57.65 Bn
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn	208.08 Bn
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn	88.26 Bn
10	Nasus Pharma	24.83 Mn	20.55 Mn	-	2.82 Mn

Download Data

Date	Value
Dec 31, 2025	2.82 Mn
Jun 30, 2025	678,000.00